Characterization of c-Kit expression and activation in KSHV-infected endothelial cells

Virology

Volumn 390, Issue 2, 2009, Pages 174-185

  Douglas, Janet L ^a   Whitford, Jill G ^a   Moses, Ashlee V ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

c kit; Endothelial cells; Herpesvirus 8; Kaposi's sarcoma; KSHV; Viral transformation

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; STEM CELL FACTOR;

ARTICLE; CELL ACTIVATION; CELL IMMORTALIZATION; CELL SUBPOPULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE INDUCTION; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; SIGNAL TRANSDUCTION; SPINDLE CELL; UPREGULATION; VIRUS TRANSFORMATION;

CELL LINE; CELLS, CULTURED; ENDOTHELIAL CELLS; HERPESVIRUS 8, HUMAN; HUMANS; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELL FACTOR; VIRUS LATENCY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

EID: 67649867945     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.05.011     Document Type: Article

References (36)

1. Adams R.H., and Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8 6 (2007) 464-478
2. Beckstead J.H., Wood G.S., and Fletcher V. Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium. Am. J. Pathol. 119 2 (1985) 294-300
3. Broudy V.C., Kovach N.L., Bennett L.G., Lin N., Jacobsen F.W., and Kidd P.G. Human umbilical vein endothelial cells display high-affinity c-kit receptors and produce a soluble form of the c-kit receptor. Blood 83 8 (1994) 2145-2152
4. Dyson N., Howley P.M., Munger K., and Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243 4893 (1989) 934-937
5. Ganem D. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu. Rev. Pathol. 1 (2006) 273-296
6. Gill P.S., Tsai Y.C., Rao A.P., Spruck III C.H., Zheng T., Harrington Jr. W.A., Cheung T., Nathwani B., and Jones P.A. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc. Natl. Acad. Sci. U.S.A. 95 14 (1998) 8257-8261
7. Grossmann C., Podgrabinska S., Skobe M., and Ganem D. Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. J. Virol. 80 14 (2006) 7179-7185
8. Herndier B., and Ganem D. The biology of Kaposi's sarcoma. Cancer Treat. Res. 104 (2001) 89-126
9. Hong Y.K., Foreman K., Shin J.W., Hirakawa S., Curry C.L., Sage D.R., Libermann T., Dezube B.J., Fingeroth J.D., and Detmar M. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat. Genet. 36 7 (2004) 683-685
10. Hsu Y.R., Wu G.M., Mendiaz E.A., Syed R., Wypych J., Toso R., Mann M.B., Boone T.C., Narhi L.O., Lu H.S., and Langley K.E. The majority of stem cell factor exists as monomer under physiological conditions. Implications for dimerization mediating biological activity. J. Biol. Chem. 272 10 (1997) 6406-6415
11. Inoue N., Winter J., Lal R.B., Offermann M.K., and Koyano S. Characterization of entry mechanisms of human herpesvirus 8 by using an Rta-dependent reporter cell line. J. Virol. 77 14 (2003) 8147-8152
12. Jussila L., Valtola R., Partanen T.A., Salven P., Heikkila P., Matikainen M.T., Renkonen R., Kaipainen A., Detmar M., Tschachler E., Alitalo R., and Alitalo K. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res. 58 8 (1998) 1599-1604
13. Kahn H.J., Bailey D., and Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod. Pathol. 15 4 (2002) 434-440
14. Koon H.B., Bubley G.J., Pantanowitz L., Masiello D., Smith B., Crosby K., Proper J., Weeden W., Miller T.E., Chatis P., Egorin M.J., Tahan S.R., and Dezube B.J. Imatinib-induced regression of AIDS-related Kaposi's sarcoma. J. Clin. Oncol. 23 5 (2005) 982-989
15. Lennartsson J., Jelacic T., Linnekin D., and Shivakrupa R. Normal and oncogenic forms of the receptor tyrosine kinase kit. Stem Cells 23 1 (2005) 16-43
16. Lennartsson J., Voytyuk O., Heiss E., Sundberg C., Sun J., and Ronnstrand L. C-Kit signal transduction and involvement in cancer. Cancer Ther. 3 (2005) 5-28
17. McCormick C., and Ganem D. The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307 5710 (2005) 739-741
18. Moses A.V., Fish K.N., Ruhl R., Smith P.P., Strussenberg J.G., Zhu L., Chandran B., and Nelson J.A. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J. Virol. 73 8 (1999) 6892-6902
19. Moses A.V., Jarvis M.A., Raggo C., Bell Y.C., Ruhl R., Luukkonen B.G., Griffith D.J., Wait C.L., Druker B.J., Heinrich M.C., Nelson J.A., and Fruh K. A functional genomics approach to Kaposi's sarcoma. Ann. N.Y. Acad. Sci. 975 (2002) 180-191
20. Moses A.V., Jarvis M.A., Raggo C., Bell Y.C., Ruhl R., Luukkonen B.G., Griffith D.J., Wait C.L., Druker B.J., Heinrich M.C., Nelson J.A., and Fruh K. Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells. J. Virol. 76 16 (2002) 8383-8399
21. Nadimi H., Saatee S., Armin A., and Toto P.D. Expression of endothelial cell markers PAL-E and EN-4 and Ia-antigens in Kaposi's sarcoma. J. Oral Pathol. 17 8 (1988) 416-420
22. Nickoloff B.J. The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch. Dermatol. 127 4 (1991) 523-529
23. Nickoloff B.J. PECAM-1 (CD31) is expressed on proliferating endothelial cells, stromal spindle-shaped cells, and dermal dendrocytes in Kaposi's sarcoma. Arch. Dermatol. 129 2 (1993) 250-251
24. Pantanowitz L., Dezube B.J., Pinkus G.S., and Tahan S.R. Histological characterization of regression in acquired immunodeficiency syndrome-related Kaposi's sarcoma. J. Cutan. Pathol. 31 1 (2004) 26-34
25. Pantanowitz L., Schwartz E.J., Dezube B.J., Kohler S., Dorfman R.F., and Tahan S.R. C-Kit (CD117) expression in AIDS-related, classic, and African endemic Kaposi sarcoma. Appl. Immunohistochem. Mol. Morphol. 13 2 (2005) 162-166
26. Phelps W.C., Yee C.L., Munger K., and Howley P.M. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53 4 (1988) 539-547
27. Riou G., Barrois M., Sheng Z.M., Duvillard P., and Lhomme C. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. Oncogene 3 3 (1988) 329-333
28. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., and Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 6 (1990) 1129-1136
29. Sharma-Walia N., Krishnan H.H., Naranatt P.P., Zeng L., Smith M.S., and Chandran B. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. J. Virol. 79 16 (2005) 10308-10329
30. Uccini S., Ruco L.P., Monardo F., Stoppacciaro A., Dejana E., La Parola I.L., Cerimele D., and Baroni C.D. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. J. Pathol. 173 1 (1994) 23-31
31. Uccini S., Sirianni M.C., Vincenzi L., Topino S., Stoppacciaro A., Lesnoni La Parola I., Capuano M., Masini C., Cerimele D., Cella M., Lanzavecchia A., Allavena P., Mantovani A., Baroni C.D., and Ruco L.P. Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am. J. Pathol. 150 3 (1997) 929-938
32. Vieira J., and O'Hearn P.M. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325 2 (2004) 225-240
33. Wandzioch E., Edling C.E., Palmer R.H., Carlsson L., and Hallberg B. Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines. Blood 104 1 (2004) 51-57
34. Wang H.W., Trotter M.W., Lagos D., Bourboulia D., Henderson S., Makinen T., Elliman S., Flanagan A.M., Alitalo K., and Boshoff C. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat. Genet. 36 7 (2004) 687-693
35. Weninger W., Partanen T.A., Breiteneder-Geleff S., Mayer C., Kowalski H., Mildner M., Pammer J., Sturzl M., Kerjaschki D., Alitalo K., and Tschachler E. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab. Invest. 79 2 (1999) 243-251
36. Xu H., Edwards J.R., Espinosa O., Banerji S., Jackson D.G., and Athanasou N.A. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors. Hum. Pathol. 35 7 (2004) 857-861